IMP

IMP (IMP) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 37,900 VND, little changed on the session, giving a market capitalization of 6.0 trillion VND.

On valuation, IMP trades at a price-to-earnings ratio of 17.8 and a price-to-book of 2.7. That is broadly in line with the Health Care sector average P/E of 18.9. Return on equity of 15.0% points to solid profitability relative to the company's equity base, above the sector average of 11.5%. Trailing earnings per share stand at 2,316 VND.

Aveluro tracks 22 news items mentioning IMP, where recent coverage skews positive (41% of articles). The most recent catalyst was a dividend announcement event — "BDG Leads Dividend Payouts with 50% Cash Dividend in July 13-17 Week". Aveluro's composite model rates IMP 6.5/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around IMP include 5 notable classified events. On Jul 13, 2026, a dividend announcement was reported: BDG (Binh Duong Garment) will pay a 50% cash dividend for 2025, the highest among 33 companies closing books July 13-17, 2026. On May 22, 2026, a leadership change was reported: Imexpharm (IMP) undergoes board restructuring after Livzon Pharmaceutical Group acquired a 67.87% stake from SK Group and other shareholders. On May 20, 2026, a leadership change was reported: Imexpharm (IMP) sees three board members resign after Lian SGP Holding, a unit of China's Livzon Pharmaceutical Group, completed a VND 6,000B (USD 240M) acquisition of a 67.87% stake, becoming the new parent. On May 20, 2026, a leadership change was reported: Imexpharm (IMP) loses three board members including Chairman Woo Sungmin on May 18, 2026, with no stated reason, just weeks after Chinese group Livzon completed a VND 6,000B tender offer for 67.87% of IMP. On May 14, 2026, a market event was reported: Imexpharm (IMP) has changed hands from Korea's SK Group to China's Livzon Pharmaceutical Group, which acquired a 67.87% controlling stake for approximately VND 6,000 billion.

The overall tone of recent coverage is negative, with 1 of 5 events carrying bearish sentiment.